Ngā hua rapu - Yousef M. Alhammad

  • E whakaatu ana i te 1 - 7 hua o te 7
Whakamahine hua
  1. 1
    The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation

    The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation mā Yousef M. Alhammad, Anthony R. Fehr

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region

    Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Interg... mā Yousef M. Alhammad, Jun Gu, Irene Boo, David J. Harrison, Kathleen McCaffrey, Patricia Vietheer, Stirling Edwards, Charles T. Quinn, Fasséli Coulibaly, Pantelis Poumbourios, Heidi E. Drummer

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity

    Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity mā Collin D. Heer, Daniel J. Sanderson, Lynden S. Voth, Yousef M. Alhammad, Mark S. Schmidt, Samuel A.J. Trammell, Stanley Perlman, Michael S. Cohen, Anthony R. Fehr, Charles Brenner

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening

    Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening mā Anu Roy, Yousef M. Alhammad, Peter R. McDonald, David K. Johnson, Junlin Zhuo, Sarah Wazir, Dana Ferraris, L. Lehtiö, Anthony K. L. Leung, Anthony R. Fehr

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase

    The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase mā Yousef M. Alhammad, M.M. Kashipathy, Anuradha Roy, Jean‐Philippe Gagné, Peter R. McDonald, Philip Gao, Louis Nonfoux, K.P. Battaile, David K. Johnson, Erik D. Holmstrom, Guy G. Poirier, Scott Lovell, Anthony R. Fehr

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice

    SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice mā Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, Catherine M. Kerr, Joseph J. O’Connor, Jessica J. Pfannenstiel, Debarati Chanda, Caden A. Miller, Nathalie Baumlin, Matthias Salathé, Robert L. Unckless, Sonia Zúñiga, Luis Enjuanes, Sunil More, Rudragouda Channappanavar, Anthony R. Fehr

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain

    High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain mā Morgan Dasovich, Junlin Zhuo, Jack A. Goodman, Ajit G. Thomas, Robert Lyle McPherson, Aravinth Kumar Jayabalan, Veronica F. Busa, Shang-Jung Cheng, Brennan A. Murphy, Karli R. Redinger, Yousef M. Alhammad, Anthony R. Fehr, Takashi Tsukamoto, Barbara S. Slusher, Jürgen Bosch, Huijun Wei, Anthony K. L. Leung

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: